Our News

08.11

2019

CPhI Worldwide 2019

Participating in CPhI Worldwide 2019 was highly successful for Pharmathen!

Read more

06.11

2019

Our company is honored with the “Salus Index Award”!

On Wednesday, the 6th of November 2019, we were honored to receive this year’s “Salus Index Award”.

Read more

23.09

2019

Pharmathen is among the finalists for the “Global Generics & Biosimilars Awards 2019”

Pharmathen is delighted to announce that it has been shortlisted as one of the finalists for the “Global Generics & Biosimilars Awards 2019”. These awards aim at rewarding ‘best practice’ in the two industries, while, at the same time, encouraging improvements in every aspect of the way business is conducted.

Read more

06.09

2019

Official Launch of the new Long-Acting Injectables Plant by the Minister of Development and Investments, Mr. Adonis Georgiadis

The new plant is part of the company’s total investment plan of over €250 million for the next five years, which will lead to the creation of at least 300 new jobs. Sapes – Rodopi, the 6th of September, 2019. Pharmathen’s new Long-Acting Injectables Unit was officially launched today by the Minister of Development and Investments, Mr. Adonis Georgiadis; during a ceremony attended by representatives of the central and local government, the scientific and business community, and the Media.

Read more

02.09

2019

CPHI 2019

For yet another year, Pharmathen participates in CPhI Worldwide exhibition 2019 in Frankfurt @Stand No 80C72.

Read more

11.07

2019

Pharmathen is among the “Diamonds of the Greek Economy 2019”

For yet another year, we received the “Diamonds of the Greek Economy” distinction at the business...

Read more

11.06

2019

Pharmathen’ s distinction for its “Business Extroversion” for yet another year!

Another great distinction for our company!

Read more

17.05

2019

Our legal team is in the “Legal 500 2019 General Counsel Powerlist: Greece & Cyprus”.

We are proud of our legal team’s distinction to be among the “Legal 500 2019 General Counsel Powerlist: Greece & Cyprus” that were honored in a reception that took place in Athens on 16 May 2019.

Read more

30.04

2019

More investments in Northern Greece!

Pharmathen proceeded to new investments and acquired an additional 27-acres land in the Industrial Park of Sapes in order to expand its innovative business.

Read more

27.02

2019

Pharmathen’s 50 years Anniversary: A brilliant history; an even brighter future!

Pharmathen’s press event for its 50-years milestone

Read more

31.01

2019

Celebrating our 50-years Anniversary!

Coming together from all around the globe, we celebrated with our people 50 years of operation...

Read more

04.01

2019

Pharmathen ranked 1st among Greek companies investing in R&D based on the 2018 EU Industrial R&D Investment Scoreboard.

For yet another year, Pharmathen has been distinguished at the “2018 EU Industrial R&D Investment Scoreboard” and is ranked first among Greek companies based on R&D spending, by investing 33% of its turnover. With annual R&D spending of 49.9 million euros in the 2017-2018 period, Pharmathen ranked 396th on this year’s list of 1,000 companies in the EU with the highest R&D expenditure.

Read more

11.10

2018

CPhI Worldwide exhibition, Madrid

Our participation in CPhI 2018 Worldwide, the world's largest pharmaceutical exhibition, has been a great opportunity for our executives to meet and interact with hundreds of customers and partners coming from around the globe.

Read more

04.10

2018

CPHI 2018

For yet another year, Pharmathen participates at CPHI 2018 in Madrid @Stand No 9F31. We look forward to see you there!

Read more

01.12

2017

Pharmathen sells its commercial operations in Greece to focus exclusively on international markets

Amsterdam, 30/11/2017: Pharmathen, a BC Partners portfolio company, announces the sale of its Greek commercial operations as part of its long-term strategy to become a leader focused on the development of innovative and complex pharmaceuticals.

Read more

31.10

2017

Impressive presence by Pharmathen in CPhI 2017

For yet another year, Pharmathen had an impressive presence at the international exhibition CPhI Worldwide 2017 which took place in Frankfurt, Germany on the 24-26 October 2017.

Read more

02.06

2015

The significant investment by BC Partners opens new perspectives for Pharmathen

The Management of Pharmathen announces the signing of a partnership agreement in principle for the acquisition of a majority stake of shares of the Group from the investment group BC Partners. Katsos family remains in the Pharmathen Group, keeping a significant stake of shares and the management of the group. 

Read more

09.12

2014

Ranking even Higher among Companies that are Distinguished for their Investments in Research

Ranking even higher among companies that are distinguished for their investments in Research on the basis of the 2014 EU Industrial R&D Investment Scoreboard.

Read more

27.11

2014

Τhe First Private Greek Company to be Funded by the European Investment Bank (EIB)

The first funding provided to a private Greek company by the European Investment Bank - ΕΙΒ has been secured by Pharmathen to support its programme concerning the Research and Development of innovative products. 

Read more

18.06

2014

LAI Technology: Breakthrough Innovation by Pharmathen

The Greek Pharmaceutical Industry Pharmathen has taken its place on the world map of innovation in the pharmaceutical field, following the most recent achievement by the department of Research and Development of innovative healthcare products, that concerns the development of Long Acting Injectable (LAI) Technology – sustained-release injectable products.

Read more